HMOX1 and Cholestatic liver disease: These results strongly suggest that the Nrf2/HO-1/bilirubin axis may play a crucial role in the development of cholestatic liver injury, and that the intervention of Nrf2/HO-1 may be a potential therapeutic target for the treatment of cholestatic liver disease.